Is it time to use more #MRI and skip repeat biopsies in #ProstateCancer active surveillance? Less active & more patient-friendly protocols? @RannikkoAntti from @helsinkiuni says there is little evidence in the literature for now. #EAU18 magazine, by @Uroweb https://t.co/fXznk20X2q
Is it time to use more #MRI and skip repeat biopsies in #ProstateCancer active surveillance? Less active & more patient-friendly protocols? @RannikkoAntti from @helsinkiuni says there is little evidence in the literature for now. #EAU18 magazine, by @Uroweb https://t.co/fXznk20X2q